Compare · ALC vs EYE
ALC vs EYE
Side-by-side comparison of Alcon Inc. (ALC) and National Vision Holdings Inc. (EYE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALC and EYE operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- ALC is the larger of the two at $33.38B, about 27.0x EYE ($1.24B).
- EYE has hit the wire 2 times in the past 4 weeks while ALC has been quiet.
- ALC has more recent analyst coverage (25 ratings vs 20 for EYE).
- Company
- Alcon Inc.
- National Vision Holdings Inc.
- Price
- $66.70-0.16%
- $16.12+4.34%
- Market cap
- $33.38B
- $1.24B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2017
- News (4w)
- 0
- 2
- Recent ratings
- 25
- 20
Alcon Inc.
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; and EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
National Vision Holdings Inc.
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. As of January 2, 2021, the company operated through 1,205 retail stores, as well as various e-commerce websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.
Latest ALC
- SEC Form SD filed by Alcon Inc.
- SEC Form 6-K filed by Alcon Inc.
- New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
- Alcon Announces Results of 2026 Annual General Meeting
- Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada
- Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026
- SEC Form 6-K filed by Alcon Inc.
- Alcon Publishes Agenda for 2026 Annual General Meeting
- Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
- Alcon Surpasses 175 Million IOLs Implanted Globally
Latest EYE
- National Vision Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- National Vision, Inc. Announces Participation in William Blair 46th Annual Growth Stock Conference
- SEC Form 10-Q filed by National Vision Holdings Inc.
- National Vision Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- National Vision Holdings, Inc. Reports First Quarter 2026 Financial Results
- SEC Form DEFA14A filed by National Vision Holdings Inc.
- SEC Form DEF 14A filed by National Vision Holdings Inc.
- Chief Legal & Strategy Officer Brandman Jared converted options into 1,890 shares and covered exercise/tax liability with 842 shares, increasing direct ownership by 1% to 77,079 units (SEC Form 4)
- SEC Form SCHEDULE 13G filed by National Vision Holdings Inc.
- National Vision Holdings, Inc. Announces First Quarter 2026 Earnings Release and Conference Call